pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    CD38-SADA
    B-Cell Non-Hodgkin Lymphoma Y-mAbs Therapeutics Inc
  • Phase 1
    CD4LVFOXP3
    Unspecified Genetic Disorders Stanford University
  • Preclinical
    CD6/CTLA4 CAR-Treg-Dermatological Basket
    Psoriasis Immuthera Inc
  • Preclinical
← prev
page 73 of 271
next →
Pain89
Neurology1
CD6/CTLA4 CAR-Treg-Neuro Basket
Amyotrophic Lateral Sclerosis
Immuthera Inc
  • Phase 2
    CDI-988
    Norovirus Infections$COCP Cocrystal Pharma, Inc.
  • Preclinical
    CDKN2A Program
    Pancreatic Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    CDR-404
    Head And Neck Squamous Cell Carcinoma (HNSC) CDR-Life Inc
  • Preclinical
    CDX Program
    Refractory Acute Myeloid Leukemia HemoGenyx Pharmaceuticals Plc
  • Preclinical
    CDX-101
    Cardax
    Hypertriglyceridemia Cardax Inc
  • Preclinical
    CDX-301
    Juvenile Macular Degeneration (Stargardt Disease) Cardax Inc
  • CEFAZOLIN
    CEFAZOLIN
    no indication HIKMA FARMACEUTICA
  • CEFEPIME
    CEFEPIME
    no indication BAXTER HLTHCARE
  • CEFOXITIN
    CEFOXITIN
    no indication ACS DOBFAR
  • CEFTRIAXONE AND DEXTROSE
    CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE)
    no indication B BRAUN
  • CEFUROXIME AND DEXTROSE
    CEFUROXIME AND DEXTROSE
    no indication B BRAUN
  • Preclinical
    CEL-4000
    Rheumatoid Arthritis CEL-SCI Corp
  • Phase 3
    CELECOXIB
    CELECOXIB
    Post-Operative Pain MedinCell SA
  • Preclinical
    CEN-501
    Allergic Rhinitis NeuCen BioMed Co Ltd
  • Phase 2
    CEP-11981
    Pancreatic Cancer$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Phase 2
    CER-1236
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$CERO CERO THERAPEUTICS HOLDINGS, INC.
  • CERETEC
    CERETEC (TECHNETIUM TC-99M EXAMETAZIME)
    no indication GE HEALTHCARE
  • CEREZYME
    CEREZYME (IMIGLUCERASE)
    no indication Genzyme Corp
  • CETIRIZINE HYDROCHLORIDE ALLERGY
    CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE)
    no indication Bionpharma Inc
  • CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
    no indication SUN PHARM INDS LTD
  • Preclinical
    CF-602
    Erectile Dysfunction$CANF Can-Fite BioPharma Ltd.
  • Phase 2
    CFI-402411
    Anal Cancer Treadwell Therapeutics Inc
  • Preclinical
    CG-923308
    Breast Cancer$GYRE GYRE THERAPEUTICS, INC.
  • Phase 1
    CG-P5 peptide
    Wet (Neovascular / Exudative) Macular Degeneration Caregen Co Ltd
  • Preclinical
    CGT-1263
    Unspecified Cancer$COGT Cogent Biosciences, Inc.
  • Preclinical
    CHA-001
    decitabine
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Cha Therapeutics Inc